or Try an Advanced Search...

    Treatment Of Cancer Stocks List

    Symbol Grade Name % Change
    CNTX B Context Therapeutics Inc. -1.00
    IMTX B Immatics N.V. -2.22
    CANF B Can-Fite Biopharma Ltd Sponsored ADR (Israel) 0.00
    ONCT B Oncternal Therapeutics, Inc. 1.21
    NRIX C Nurix Therapeutics, Inc. 1.09
    RNA C Avidity Biosciences, Inc. -0.74
    CATX C Perspective Therapeutics, Inc. 4.55
    AEZS C AEterna Zentaris Inc. -2.42
    TGTX C TG Therapeutics, Inc. -3.49
    IGMS C IGM Biosciences, Inc. -4.36
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Long-Term Care Facilities Medical Care Medical Instruments & Supplies Other Scientific & Technical Instruments
    Related Stock Lists: Cancer Biopharmaceutical Biotechnology Life Sciences Lymphoma Medicine Solid Tumors Clinical Medicine Disease Advanced Solid Tumors Biology Cancer Treatment Personalized Medicine Specialty Drugs Tumor Alcohol Analytical Services Anatomical Pathology Anemia Antibody Drug Conjugate

    Related ETFs - A few ETFs which own one or more of the above listed Treatment Of Cancer stocks.

    Symbol Grade Name Weight
    ULTY D Tidal Trust II YieldMax Ultra Option Income Strategy ETF 5.68
    SBIO D ALPS Medical Breakthroughs ETF 4.62
    BBC D Virtus LifeSci Biotech Clinical Trials ETF 4.5
    PBE C PowerShares Dynamic Biotech & Genome 3.5
    OZEM D Roundhill GLP-1 & Weight Loss ETF 3.31
    View all Treatment Of Cancer ETFs...
    Compare ETFs
    Compare BBC to OZEM Compare ULTY to BBC Compare ULTY to PBE

        Treatment Of Cancer Stocks Recent News

        Date Stock Title
        May 31 TGTX TG Therapeutics Announces Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the 2024 Consortium of Multiple Sclerosis Centers Annual Meeting
        May 30 ONCT Oncternal Announces Enrollment Completed and Dosing Initiated for Fifth Dose Cohort of Phase 1/2 Study of ONCT-534 for the Treatment of R/R Metastatic Castration-Resistant Prostate Cancer
        May 30 TGTX Despite shrinking by US$192m in the past week, TG Therapeutics (NASDAQ:TGTX) shareholders are still up 131% over 5 years
        May 30 IGMS We're Keeping An Eye On IGM Biosciences' (NASDAQ:IGMS) Cash Burn Rate
        May 29 AEZS Aeterna Zentaris Provides Update on Timing for Annual Meeting of Shareholders and Due Bill Redemption Date
        May 29 RNA Avidity Biosciences to Present Preliminary Data from Phase 1/2 FORTITUDE™ Trial of AOC 1020 in People Living with Facioscapulohumeral Muscular Dystrophy at 31st Annual FSHD Society International Research Congress
        May 29 AEZS Ceapro's Q1 Net Loss Swells YoY, But Talks Up Benefits of Planned Aeterna Merger
        May 29 RNA 2 Potentially High-Reward Growth Stocks to Buy Right Now
        May 29 CANF Independent Scientists Published a Review Article Demonstrating That Can-Fite Drugs Have Therapeutic Effects on Heart Diseases
        May 29 IGMS IGM Biosciences to Present at the Jefferies Healthcare Conference
        May 29 NRIX Nurix Therapeutics to Participate in the Jefferies Global Healthcare Conference
        May 28 TGTX TG Therapeutics Announces Schedule of Upcoming Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the 2024 Consortium of Multiple Sclerosis Centers Annual Meeting
        May 28 NRIX Nurix Therapeutics appoints Paula O’Connor as chief medical officer
        May 28 NRIX Nurix Therapeutics Appoints Paula G. O’Connor, M.D., as Chief Medical Officer and Pasit Phiasivongsa, Ph.D., as Chief Technical Officer
        May 27 CATX Perspective Therapeutics: An Elevated Theranostics Play Flying Under Your Radar
        May 27 CANF Can-Fite to Participate in Partnering Meetings at Bio International Convention 2024
        Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Long-Term Care Facilities Medical Care Medical Instruments & Supplies Other Scientific & Technical Instruments
        Related Stock Lists: Cancer Biopharmaceutical Biotechnology Life Sciences Lymphoma Medicine Solid Tumors Clinical Medicine Disease Advanced Solid Tumors Biology Cancer Treatment Personalized Medicine Specialty Drugs Tumor Alcohol Analytical Services Anatomical Pathology Anemia Antibody Drug Conjugate
        Treatment Of Cancer

        Treatment of cancer depends on the type and stage of the cancer, as well as the patient's overall health and preferences. Treatment options may include surgery, radiation therapy, chemotherapy, immunotherapy, targeted therapy, and/or hormone therapy. In some cases, a combination of treatments may be used.

        Browse All Tags